Haemonetics Corp/mass (HAE) — Who Owns This Stock? 13F Breakdown (Q2 2026)

HAE ranks #1898 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

HAE is a disclosed holding of Cliff Asness (AQR Capital Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.1% of that fund's own 13F portfolio.

331 institutions disclose a position in HAE, but none treat it as a major bet — even North Peak Capital Management, LLC, its most concentrated holder, allocates just 2.9% of its own portfolio to it.

Quantinno Capital Management LP has added to its HAE position for two straight quarters, increasing it by $5.0M to reach $5.5M today.

Cliff Asness has trimmed its HAE position for two straight quarters, cutting it by $88.5M while still holding $165.0M.

HAE is down 1.6% today, but institutions show net buying of $575.8M this quarter — a divergence between today's price move and the underlying institutional flow.

HAE posted net income of $96.3M over the trailing twelve months, and currently trades at a P/E of 52.4.

• Profitable — net income of $96.3M over the trailing twelve months
• Revenue declined 0.6% year over year
• Net income declined year over year, from $167.7M to $96.3M
• Generated $293.2M in positive operating cash flow
• Current ratio of 2.95x — enough short-term assets to cover short-term liabilities
• Liabilities run 3.01x equity — a highly leveraged balance sheet worth noting